BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1693644)

  • 1. The use of human T-lymphocyte clones to study T-cell function in allergic contact dermatitis to urushiol.
    Kalish RS
    J Invest Dermatol; 1990 Jun; 94(6 Suppl):108S-111S. PubMed ID: 1693644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation and cloning of human urushiol specific peripheral blood T-cells: isolation of urushiol triggered suppressor T-cells.
    Kalish RS; Morimoto C
    J Invest Dermatol; 1989 Jan; 92(1):46-52. PubMed ID: 2521239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urushiol (poison ivy)-triggered suppressor T cell clone generated from peripheral blood.
    Kalish RS; Morimoto C
    J Clin Invest; 1988 Sep; 82(3):825-32. PubMed ID: 2458387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enrichment and function of urushiol (poison ivy)-specific T lymphocytes in lesions of allergic contact dermatitis to urushiol.
    Kalish RS; Johnson KL
    J Immunol; 1990 Dec; 145(11):3706-13. PubMed ID: 2147199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Processing of urushiol (poison ivy) hapten by both endogenous and exogenous pathways for presentation to T cells in vitro.
    Kalish RS; Wood JA; LaPorte A
    J Clin Invest; 1994 May; 93(5):2039-47. PubMed ID: 7910172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of hapten-specific tolerance of human CD8+ urushiol (poison ivy)-reactive T lymphocytes.
    Kalish RS; Wood JA
    J Invest Dermatol; 1997 Mar; 108(3):253-7. PubMed ID: 9036920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro studies of poison oak immunity. II. Effect of urushiol analogues on the human in vitro response.
    Byers VS; Castagnoli N; Epstein WL
    J Clin Invest; 1979 Nov; 64(5):1449-56. PubMed ID: 315415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro studies of poison oak immunity. I. In vitro reaction of human lymphocytes to urushiol.
    Byers VS; Epstein WL; Castagnoli N; Baer H
    J Clin Invest; 1979 Nov; 64(5):1437-48. PubMed ID: 315414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A murine model system for contact sensitization to poison oak or ivy urushiol components.
    Dunn IS; Liberato DJ; Dennick RG; Castagnoli N; Byers VS
    Cell Immunol; 1982 Apr; 68(2):377-88. PubMed ID: 6178516
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on poison ivy. In vitro lymphocyte transformation by urushiol-protein conjugates.
    Dupuis G
    Br J Dermatol; 1979 Dec; 101(6):617-24. PubMed ID: 161173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keratinocyte intercellular adhesion molecule-1 (ICAM-1) expression precedes dermal T lymphocytic infiltration in allergic contact dermatitis (Rhus dermatitis).
    Griffiths CE; Nickoloff BJ
    Am J Pathol; 1989 Dec; 135(6):1045-53. PubMed ID: 2574536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of tolerance to poison ivy urushiol in the guinea pig by epicutaneous application of the structural analog 5-methyl-3-n-pentadecylcatechol.
    Stampf JL; Benezra C; Byers V; Castagnoli N
    J Invest Dermatol; 1986 May; 86(5):535-8. PubMed ID: 2943824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the contact sensitivity response to urushiol with anti-urushiol monoclonal antibody ALG 991.
    Baldwin RW; Clegg JA; Curran AC; Austin EB; Khan T; Ma Y; Gunn B; Hudecz F; Byers VS; Lepoittevin JP; Price MR
    Arch Dermatol Res; 1999 Dec; 291(12):652-8. PubMed ID: 10651166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of murine contact sensitivity to urushiol components by serum factors.
    Dunn IS; Liberato DJ; Stampf JL; Castagnoli N; Byers VS
    J Invest Dermatol; 1987 Sep; 89(3):296-8. PubMed ID: 3624902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of chemical reactivity of urushiol-type haptens on sensitization and the induction of tolerance.
    Dunn IS; Liberato DJ; Castagnoli N; Byers VS
    Cell Immunol; 1986 Jan; 97(1):189-96. PubMed ID: 3742608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservation of allergic contact dermatitis to poison ivy (urushiol) in late HIV disease. The implications and relevance to immunotherapy with contact allergens.
    Smith KJ; Skelton HG; Nelson A; Wagner KF; Hackley BE
    Dermatology; 1997; 195(2):145-9. PubMed ID: 9310722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments in the pathogenesis of allergic contact dermatitis.
    Kalish RS
    Arch Dermatol; 1991 Oct; 127(10):1558-63. PubMed ID: 1929465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New GLC analysis of urushiol congeners in different plant parts of poison ivy, Toxicodendron radicans.
    Craig JC; Waller CW; Billets S; Elsohly MA
    J Pharm Sci; 1978 Apr; 67(4):483-5. PubMed ID: 641754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptome profiling reveals Th2 bias and identifies endogenous itch mediators in poison ivy contact dermatitis.
    Liu B; Tai Y; Liu B; Caceres AI; Yin C; Jordt SE
    JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184997
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.